BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37909353)

  • 1. Economic Costs of Diabetes in the U.S. in 2022.
    Parker ED; Lin J; Mahoney T; Ume N; Yang G; Gabbay RA; ElSayed NA; Bannuru RR
    Diabetes Care; 2024 Jan; 47(1):26-43. PubMed ID: 37909353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic Costs of Diabetes in the U.S. in 2017.
    American Diabetes Association
    Diabetes Care; 2018 May; 41(5):917-928. PubMed ID: 29567642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of diabetes in the U.S. in 2012.
    American Diabetes Association
    Diabetes Care; 2013 Apr; 36(4):1033-46. PubMed ID: 23468086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic costs of diabetes in the US in 2002.
    Hogan P; Dall T; Nikolov P;
    Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.
    Diabetes Care; 1998 Feb; 21(2):296-309. PubMed ID: 9539999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic Costs Attributable to Diabetes in Each U.S. State.
    Shrestha SS; Honeycutt AA; Yang W; Zhang P; Khavjou OA; Poehler DC; Neuwahl SJ; Hoerger TJ
    Diabetes Care; 2018 Dec; 41(12):2526-2534. PubMed ID: 30305349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic burden of schizophrenia in the United States in 2002.
    Wu EQ; Birnbaum HG; Shi L; Ball DE; Kessler RC; Moulis M; Aggarwal J
    J Clin Psychiatry; 2005 Sep; 66(9):1122-9. PubMed ID: 16187769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes.
    Dall TM; Yang W; Halder P; Pang B; Massoudi M; Wintfeld N; Semilla AP; Franz J; Hogan PF
    Diabetes Care; 2014 Dec; 37(12):3172-9. PubMed ID: 25414388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect Costs.
    Bebo B; Cintina I; LaRocca N; Ritter L; Talente B; Hartung D; Ngorsuraches S; Wallin M; Yang G
    Neurology; 2022 May; 98(18):e1810-e1817. PubMed ID: 35418457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Economic Burden of Elevated Blood Glucose Levels in 2017: Diagnosed and Undiagnosed Diabetes, Gestational Diabetes Mellitus, and Prediabetes.
    Dall TM; Yang W; Gillespie K; Mocarski M; Byrne E; Cintina I; Beronja K; Semilla AP; Iacobucci W; Hogan PF
    Diabetes Care; 2019 Sep; 42(9):1661-1668. PubMed ID: 30940641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The national economic burden of rare disease in the United States in 2019.
    Yang G; Cintina I; Pariser A; Oehrlein E; Sullivan J; Kennedy A
    Orphanet J Rare Dis; 2022 Apr; 17(1):163. PubMed ID: 35414039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Economic Burden of Nocturia on the U.S. Health Care System and Society: A National Health and Nutrition Examination Survey Analysis.
    Jhaveri J; Gauthier-Loiselle M; Gagnon-Sanschagrin P; Wu EQ
    J Manag Care Spec Pharm; 2019 Dec; 25(12):1398-1408. PubMed ID: 31566054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costs of illness: United States, 1980.
    Parsons PE; Lichtenstein R; Berki SE; Murt HA; Lepkowski JM; Stehouwer SA; Landis JR
    Natl Med Care Util Expend Surv C; 1986 Apr; (3):1-90. PubMed ID: 10313412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic burden of diabetes.
    Dall TM; Zhang Y; Chen YJ; Quick WW; Yang WG; Fogli J
    Health Aff (Millwood); 2010 Feb; 29(2):297-303. PubMed ID: 20075080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The economic burden of vision loss and eye disorders among the United States population younger than 40 years.
    Wittenborn JS; Zhang X; Feagan CW; Crouse WL; Shrestha S; Kemper AR; Hoerger TJ; Saaddine JB;
    Ophthalmology; 2013 Sep; 120(9):1728-35. PubMed ID: 23631946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Economic Burden of Vision Loss and Blindness in the United States.
    Rein DB; Wittenborn JS; Zhang P; Sublett F; Lamuda PA; Lundeen EA; Saaddine J
    Ophthalmology; 2022 Apr; 129(4):369-378. PubMed ID: 34560128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of occupational injury and illness in the United States.
    Leigh JP
    Milbank Q; 2011 Dec; 89(4):728-72. PubMed ID: 22188353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.
    Kuenzig ME; Lee L; El-Matary W; Weizman AV; Benchimol EI; Kaplan GG; Nguyen GC; Bernstein CN; Bitton A; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S34-S41. PubMed ID: 31294383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.